In humans, higher body mass index (BMI) has been shown to be independently associated with high Cystatin C levels in the absence of any clinically recognized chronic kidney disease (CKD) [24] and high Cystatin C levels are also correlated with accumulation of epicardial adipose tissue, a cardiovascular risk factor independent of renal function decline [25]. Here, CST3 is linked to chronic kidney disease.